TBVAC2020 project members

Coordinator

Partners in TBVAC2020 are:

Australia

University of Sydney

Belgium

Ghent University

Belgium

GSK Biologicals

Belgium

Scientific Institute of Public Health (WIV-ISP)

Belgium

Université Libre de Bruxelles

Denmark

Statens Serum Institut (SSI)

France

Centre National de la Recherche Scientifique (CNRS)

France

Institut Pasteur de Lille

France

Institut Pasteur (Paris)

France

Transgene

Germany

Max-Planck-Institute for Infection Biology

Germany

Friedrich-Loeffler-Institut

Germany

University of  Ulm

Ireland

University College Dublin

Italy

Azienda Ospedaliera Universitaria Policlinico “Paolo Giaccone” di Palermo

Italy

IRCCS Lazzaro Spallanzani

Italy

Istituto Superiore Di Sanità (ISS)

Republic of Korea

Yonsei University College of Medicine

Republic of Korea

International Tuberculosis Research Center

South Africa

K-Rith Kwazulu-Natal Research Institute for Tuberculosis

South Africa

South African Tuberculosis Vaccine Institute (SATVI)

South Africa

Stellenbosch University

South Africa

University of Cape Town

Spain

Fundació Institut d’ Investigació en Ciències de la Salut Germans Trias i Pujol

Spain

University of Zaragoza 

Switzerland

Centre Hospital Universitaire Vaudois

Switzerland

ETH Zürich – Institute of Molecular Systems Biology

Switzerland

University of Basel

Switzerland

University of Geneva

Switzerland

University of Lausanne

Switzerland

University of Zürich

The Gambia

Medical Research Council

The Netherlands

Biomedial Primate research Centre

The Netherlands

Leiden University Medical Center (LUMC)

The Netherlands

 Tuberculosis Vaccine Initiative (TBVI)

United Kingdom

Aston University

United Kingdom

 Bangor University

United Kingdom

Imperial College, Faculty of Medicine, Department of Medicine & School of Public Health

United Kingdom

London School of Hygiene and Tropical Medicine (LSHTM)

United Kingdom

 Bangor UThe secretary of state for health (DH) acting through PHE andniversity

United Kingdom

MHRA

United Kingdom

University of Oxford

United Kingdom

Animal and Plant Health Agency (APHA)

United Kingdom

St. George’s University of London,

United Kingdom

EMI-TB

United Kingdom

Aeras TB vaccine clinical programme was transferred in 2018 to IAVI.